LifeStance Health (LFST) Invested Capital (2020 - 2026)

LifeStance Health has disclosed Invested Capital across 7 years of filings, most recently posting $1.5 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 1.39% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 1.39% YoY), while the FY2025 annual figure was $1.5 billion, up 5.17% from the prior year.
• Invested Capital eased to $1.5 billion in Q1 2026, from $1.5 billion in the prior quarter.
• Over the last five years, Invested Capital for LFST reached as high as $1.6 billion in Q1 2022 and fell as low as $1.4 billion in Q1 2024.
• The 5-year median for Invested Capital is $1.5 billion (2026), against an average of $1.5 billion.
• Annual changes were most pronounced in 2022 — Invested Capital jumped 63.1% — and 2023, when it dropped 6.35%.
• A 5-year view of Invested Capital shows it stood at $1.5 billion in 2022, then fell by 6.35% to $1.4 billion in 2023, then climbed by 0.64% to $1.4 billion in 2024, then rose by 5.17% to $1.5 billion in 2025, then declined by 2.87% to $1.5 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $1.5 billion, $1.5 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.